Hysterectomy may be less expensive for teenagers with Medicare.

Published Date: 08 Mar 2023

Medicare covers people with disabilities who are young enough to get pregnant. Contraception is often not covered for these patients and they opt for hysterectomy or tubal ligation, which may be covered.

Read Full News

Latest News

Can Cycle Charting Change How We Treat Women?

Menstrual cycle patterns can reveal clinically relevant changes in hormonal and overall health, yet this patient-generated data remains largely overlooked in practice.

Canada’s Alcohol Consumption Guidance: A Roundtable Discussion

Dr Peter Butt of the University of Saskatchewan and Dr Jürgen Rehm of the Centre for Addiction and Mental Health discuss an objective approach to advising patients on alcohol.

Who Should Decide for Cognitively Impaired Patient: Ethicist

Ethicist Art Caplan discusses the difficulties associated with adult patients who have lost their cognitive capacity.

Choosing the Right COVID Prophylaxis

Your patient’s grandmother was just exposed to COVID. Should you go with PrEP, PEP, or masks alone?

Seeing a Tick Bite Case? Run This Treatment Checklist

Most tick bites call for monitoring, not medication. Here's the exception and the window that matters.

IL-6 Receptor Inhibitors Beat Conventional Therapy in PMR

Patients with polymyalgia rheumatica who cannot tolerate glucocorticoids or experience relapse may benefit from IL-6 receptor inhibitor therapy vs standard immunomodulatory options.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

Menstrual cycle patterns can reveal clinically relevant changes in hormonal and overall health, yet this patient-generated data remains largely overlooked in practice.

Dr Peter Butt of the University of Saskatchewan and Dr Jürgen Rehm of the Centre for Addiction and Mental Health discuss an objective approach to advising patients on alcohol.

Ethicist Art Caplan discusses the difficulties associated with adult patients who have lost their cognitive capacity.

Your patient’s grandmother was just exposed to COVID. Should you go with PrEP, PEP, or masks alone?

Most tick bites call for monitoring, not medication. Here's the exception and the window that matters.

Patients with polymyalgia rheumatica who cannot tolerate glucocorticoids or experience relapse may benefit from IL-6 receptor inhibitor therapy vs standard immunomodulatory options.

News All Time

Antibiotic Overuse Persists in Community-Acquired Pneumonia

Discordant tests haven’t discouraged antibiotic coverage for methicillin-resistant Staphylococcus aureus.

What Changes When the Patient Is European?

European visitors may not change the medicine, but they do change the consultation — forcing faster diagnostics, clearer communication, and tighter follow-up plans.

Doctors' Groups Welcome New Training Posts

The BMA and RCP welcomed 350 new training posts for resident doctors but said the government must go further to fix shortages.

When Does Hospital Noise Become a Health Alarm for Doctors?

Persistent hospital noise can increase stress, disrupt communication, and contribute to alarm desensitization, raising concerns about clinician well-being and patient safety.

Barrett Esophagus May Strike Decades Before Official Diagnosis

Professor Kit Curtius and graduate student Samuel Reynolds discuss their research on Barrett esophagus onset age, presented at DDW 2026.

Immune-Mediated Disease in Pregnancy Shapes Care Choices

Conflicting recommendations and limited evidence leave clinicians weighing disease control against medication risks across pregnancy, delivery, and breastfeeding.

EWG Scores vs Real Risk: How to Counsel Your Patients

Patients are skipping sunscreen, citing EWG’s low sunscreen approval rate. Here’s what EWG’s 20% figure means, and why DIY substitutes are harmful.

Doula Care Often Out of Reach for Mothers

Virginia Medicaid covers doula care, but low pay and complicated paperwork are making it harder for moms on Medicaid to find doulas who will accept their insurance.

Substance Use Disorders Decline but Treatment Gap Persists

Substance use and related disorders declined among teens and young adults, but millions of Americans with addiction still go untreated, new national survey data show.

Simple Reminders Boost Lung Cancer Screening Rates

Reminders sent to both primary care doctors and patients may substantially increase adherence to annual lung cancer screening.

Is Measles in Yemen a Threat to the Broader Region?

Yemen now ranks third highest in the world for measles cases, a sign of its collapsing healthcare system.

Late-Onset Epilepsy Differs From Alzheimer Disease

Patients with late-onset temporal lobe epilepsy and normal Alzheimer biomarkers show a distinct cognitive and CSF pattern than those with mild cognitive impairment due to Alzheimer disease.

Eye Doctors Urge Caution Ahead of UK Solar Eclipse

On Wednesday evening, the moon will cover up to 96% of the sun in the UK's deepest eclipse since 1999.

Pediatricians Sidestep Trump CDC Vaccine Guidance

Growing distrust of the CDC has prompted pediatricians and health departments to seek independent vaccine guidance.

Antibody Drug Shows Promise in Refractory Lymphoma

Loncastuximab tesirine shows promise for patients with diffuse large B-cell lymphoma after multiple treatments, including relapse following chimeric antigen receptor T-cell therapy.

When Cost-Saving Software Undermines GP Prescribing

As part of the BMA's collective action, GPs are switching off prescribing prompts that critics say put cost ahead of patient care.

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Older Adults With Advanced Cancer Prioritize Quality of Life

FDA approves rivanetin as the first-line treatment for lung cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Comprehensive Updates in Hematology and Quality Improvement 

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Rehabilitation of Physical Endurance Following Prolonged Cytopenic States 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

1.

Emerging Advances in Hematology and Quality Improvement

2.

Practical Breakthroughs in Oncology Across Clinical Settings

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Signs and Symptoms of Leukemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot